Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2021 Publisher: Grünenthal Ltd., 1 Stokenchurch Business Park, Ibstone Road, Stokenchurch, England, HP14 3FE, UK
ZYDOL 50 mg/ml Solution for Injection.
| Pharmaceutical Form |
|---|
|
Clear glass ampoules containing injectable solution. Solution for injection or infusion. |
Each ZYDOL Solution for Injection ampoule contains 100mg tramadol hydrochloride in 2ml colourless aqueous solution.
For the full list of excipients, see Section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Tramadol |
Tramadol is a centrally acting opioid analgesic. It is a non selective pure agonist at μ-, δ- and κ-opioid receptors with a higher affinity for the μ-receptor. Other mechanisms which may contribute to its analgesic effect are inhibition of neuronal reuptake of noradrenaline and enhancement of serotonin release. Tramadol has an antitussive effect. In contrast to morphine, analgesic doses of tramadol over a wide range have no respiratory depressant effect. |
| List of Excipients |
|---|
|
ZYDOL ampoules contain: Water for injection |
Clear glass ampoules containing 2ml of tramadol hydrochloride in a box of 5 ampoules.
Grünenthal Ltd., 1 Stokenchurch Business Park, Ibstone Road, Stokenchurch, England, HP14 3FE, UK
PL 21727/0002
05/03/2009
| Drug | Countries | |
|---|---|---|
| ZYDOL | Australia, Ireland, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
